Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial
Journal of Urology | May 23, 2019 | Volume: 202 | Issue: 5 | Pages: 920-926
10.1097/ju.0000000000000355
| PMID 31120373